Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions
Authors
Keywords
-
Journal
PATHOLOGY & ONCOLOGY RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-16
DOI
10.1007/s12253-020-00861-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer
- (2019) Till Eichenauer et al. Oncotarget
- PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer
- (2018) Marie-Christine Heinrich et al. BMC CANCER
- Sa1621 - Ezh2 Regulates Sfrp4 Expression without Affecting the Hypermethylation of Sfrp4 in Colorectal Cancer Cell Line
- (2018) Yuting Liu et al. GASTROENTEROLOGY
- 13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancer
- (2018) Martina Kluth et al. GENES CHROMOSOMES & CANCER
- An Indispensable Role of Androgen Receptor in Wnt Responsive Cells During Prostate Development, Maturation, and Regeneration
- (2018) Yongfeng He et al. STEM CELLS
- Increased immune infiltration and chemokine receptor expression in head and neck epithelial tumors after neoadjuvant immunotherapy with the IRX-2 regimen
- (2018) Neil L. Berinstein et al. OncoImmunology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Wnt receptor Frizzled 8 is a target of ERG in prostate cancer
- (2018) Balabhadrapatruni V. S. K. Chakravarthi et al. PROSTATE
- Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancer
- (2017) Martina Kluth et al. Oncotarget
- Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer
- (2017) Asmus Heumann et al. Scientific Reports
- SFRP4 gene expression is increased in aggressive prostate cancer
- (2017) Elise Sandsmark et al. Scientific Reports
- Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens
- (2016) Guido Sauter et al. EUROPEAN UROLOGY
- p16 upregulation is linked to poor prognosis in ERG negative prostate cancer
- (2016) Christoph Burdelski et al. TUMOR BIOLOGY
- Deletion of 18q is a strong and independent prognostic feature in prostate cancer
- (2016) Martina Kluth et al. Oncotarget
- Deletion of 8p is an independent prognostic parameter in prostate cancer
- (2016) Martina Kluth et al. Oncotarget
- Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters
- (2015) Nathaniel Melling et al. CARCINOGENESIS
- Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer
- (2015) C. Burdelski et al. CLINICAL CANCER RESEARCH
- Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers
- (2015) Christoph Burdelski et al. INTERNATIONAL JOURNAL OF CANCER
- Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion
- (2015) KATHARINA GRUPP et al. ONCOLOGY REPORTS
- Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers
- (2015) Christoph Burdelski et al. PLoS One
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer
- (2015) Martina Kluth et al. Oncotarget
- Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy
- (2015) Martin Mørck Mortensen et al. Scientific Reports
- A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling
- (2014) Eric A. Klein et al. EUROPEAN UROLOGY
- The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression
- (2014) Katharina Grupp et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical significance of different types ofp53gene alteration in surgically treated prostate cancer
- (2014) Martina Kluth et al. INTERNATIONAL JOURNAL OF CANCER
- Secreted frizzled-related protein 4 and its implications in cancer and apoptosis
- (2014) Sebastian Pohl et al. TUMOR BIOLOGY
- A Rare Human Syndrome Provides Genetic Evidence that WNT Signaling Is Required for Reprogramming of Fibroblasts to Induced Pluripotent Stem Cells
- (2014) Jason Ross et al. Cell Reports
- Expression profile and function of Wnt signaling mechanisms in malignant mesothelioma cells
- (2013) Simon A. Fox et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Secreted frizzled related proteins: Implications in cancers
- (2013) Rohit Surana et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer
- (2013) Joachim Weischenfeldt et al. CANCER CELL
- ERG Is a Critical Regulator of Wnt/LEF1 Signaling in Prostate Cancer
- (2013) L. Wu et al. CANCER RESEARCH
- CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer
- (2013) L. Burkhardt et al. CANCER RESEARCH
- Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy
- (2013) Katharina Grupp et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Evaluation of p16INK4a Overexpression in a Large Series of Cervical Carcinomas
- (2013) Cristina Pérez et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressiveERGfusion-positive prostate cancers
- (2013) Antje Krohn et al. JOURNAL OF PATHOLOGY
- Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions
- (2013) Martina Kluth et al. MODERN PATHOLOGY
- The Wnt Gatekeeper SFRP4 Modulates EMT, Cell Migration and Downstream Wnt Signalling in Serous Ovarian Cancer Cells
- (2013) Caroline E. Ford et al. PLoS One
- Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy
- (2013) Nicholas Erho et al. PLoS One
- Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
- (2012) Antje Krohn et al. AMERICAN JOURNAL OF PATHOLOGY
- Loss of Secreted Frizzled-Related Protein 4 Correlates with an Aggressive Phenotype and Predicts Poor Outcome in Ovarian Cancer Patients
- (2012) Francis Jacob et al. PLoS One
- An Accurate Prostate Cancer Prognosticator Using a Seven-Gene Signature Plus Gleason Score and Taking Cell Type Heterogeneity into Account
- (2012) Xin Chen et al. PLoS One
- TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
- (2011) Jan C Brase et al. BMC CANCER
- Diagnosis of Prostate Cancer Using Differentially Expressed Genes in Stroma
- (2011) Z. Jia et al. CANCER RESEARCH
- ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy
- (2011) Sarah Minner et al. CLINICAL CANCER RESEARCH
- The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers
- (2011) Ronald Simon INTERNATIONAL JOURNAL OF ONCOLOGY
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- In silico Estimates of Tissue Components in Surgical Samples Based on Expression Profiling Data
- (2010) Y. Wang et al. CANCER RESEARCH
- FZD4 as a Mediator of ERG Oncogene-Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells
- (2010) S. Gupta et al. CANCER RESEARCH
- ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer
- (2010) Paolo Kunderfranco et al. PLoS One
- High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer
- (2010) Sarah Minner et al. PROSTATE
- SFRP4 was overexpressed in colorectal carcinoma
- (2009) Dan Huang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A Wnt Survival Guide: From Flies to Human Disease
- (2009) Andy J. Chien et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Promoter methylation of SFRPs gene family in cervical cancer
- (2008) Ming-Tzeung Chung et al. GYNECOLOGIC ONCOLOGY
- Clinical significance of p53 alterations in surgically treated prostate cancers
- (2008) Thorsten Schlomm et al. MODERN PATHOLOGY
- Hypermethylation and aberrant expression of secreted fizzled-related protein genes in pancreatic cancer
- (2008) Xian-Min Bu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer
- (2008) Scott A. Tomlins et al. NEOPLASIA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started